Avid Bioservices Inc (CDMO): Dmitry Gabrilovich : Peregrine Pharmaceu...

Send PM Follow Ignore

Followers	85
Posts	12714
Boards Moderated	0
Alias Born	10/12/2010

biopharm

Re: biopharm post# 198681

Saturday, 12/27/2014 6:39:03 PM

Saturday, December 27, 2014 6:39:03 PM

Dmitry Gabrilovich : Peregrine Pharmaceuticals KOL : International Conference on Immunochemotherapy

The very long chain of posts covering all areas of Dmitry Gabrilovich and his expert view on MDSC's continues and how they are directly related to immunotherapy and yes, eventually will be completely all tied right into Bavituximab and Peregrine Pharmaceuticals.

For now though... pieces of the puzzle, including some interesting speakers coming up here in April, including Peregrine KOL Dmitry Gabrilovich.

------------------------------------------------------

International Conference on Immunochemotherapy

April 16-17, 2015

Lankenau Institute for Medical Research |
Philadelphia, USA |

http://10times.com/international-conference-on-immunochemotherapy/speakers

"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline." -- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!